Our Medicines

Our Medicines

Our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.

We are focused on helping millions of patients around the world in disease areas such as oncology, haematology, cardiology, immunology, fibrosis and specialty medicines. Through our Research & Development organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.

For information about our products:

Learn more

Learn more

Learn more

 

 

Reporting of side effects

Healthcare Professionals:

Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance at www.hpra.ie. Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com

Patients:

Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via HPRA Pharmacovigilance at www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. Side effects should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com

 

 

 

NOIE2012089-01 Date of Preparation: December 2020